Obalon Therapeutics (NASDAQ:OBLN) reported Q3 sales of $44.00 thousand. Earnings fell to a loss of $1.56 million, resulting in a 62.5% decrease from last quarter.

Obalon Therapeutics, Inc. is a commercial-stage medical device company focused on developing and commercializing medical devices to treat obese and overweight people by facilitating weight loss.

Delay 15 min. arrow_downward. 3,48. Dólar ( USD - $). 12 Mar 2021 About Obalon Therapeutics, Inc. Obalon Therapeutics, Inc. (NASDAQ:OBLN) is a San Diego-based company focused on developing and Obalon Therapeutics, Inc. is a commercial-stage medical device company, they focus on developing and commercializing medical devices to treat obese and 20 Jan 2021 ReShape Lifesciences Inc. to Merge With Obalon Therapeutics, Inc. to Expand Weight Loss Product Offering - read this article along with other (OBLN) Cotação da empresa Obalon Therapeutics com preços de ações, gráfico, forum, dividendos e balanços na bolsa de valores da NASDAQ. Obalon Therapeutics Inc is primarely in the business of surgical & medical instruments & apparatus.

Obalon therapeutics

See insights on Obalon Therapeutics including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. Visit Our Website & Sign Up for our FREE Email Newsletter @ https://www.BullishCharts.com We Are Also On Several Social Media Networks: #Telegram | https:// obalon merger investigation: halper sadeh llp announces investigation into whether the merger of obalon therapeutics, inc. is fair to shareholders; investors are encouraged to contact the firm – obln. january 21, 2021.

The Investor Relations website contains information about Obalon Therapeutics's business for stockholders, potential investors, and financial analysts.

Patients with prior weight loss surgeries are not eligible. ReShape Lifesciences Inc. to Merge With Obalon Therapeutics, Inc. to Expand Weight Loss Product Offering Provided by Accesswire Jan 20, 2021 1:45 PM UTC Obalon Therapeutics (NASDAQ:OBLN) reported Q3 sales of $44.00 thousand.

Obalon Therapeutics, Inc. is a commercial-stage medical device company focused on developing and commercializing medical devices to treat obese and overweight people by facilitating weight loss.

SAN DIEGO, March 12, 2021 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical Köp aktier i Obalon Therapeutics Inc - enkelt och billigt hos Avanza Bank. Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage. 2021-01-20 · Shares of Obalon Therapeutics Inc. OBLN, +5.34% blasted six-fold higher on massive volume in afternoon trading Wednesday, after the weight loss technologies company announced an agreement to merge Köp aktien Obalon Therapeutics, Inc. (OBLN). Hos Nordnet kan du handla från 0 kr i courtage. Klicka här för att följa aktiekursen i realtid 2021-01-20 · (RTTNews) - Shares of Obalon Therapeutics Inc. (OBLN) surged over 75% on Wednesday morning on the news that the company will merger with ReShape Lifesciences Inc. OBLN is currently trading at $2 OBLN: Get the latest Obalon Therapeutics stock price and detailed information including OBLN news, historical charts and realtime prices. (RTTNews) - Shares of Obalon Therapeutics Inc. (OBLN) surged over 75% on Wednesday morning on the news that the company will merger with ReShape Lifesciences Inc. 1 dag sedan · Obalon Therapeutics Inc. (OBLN) shares rose by 11.42% to trade at $3.22 in premarket at the time of writing.

2020-12-02 The Obalon Balloon System is intended for adults with a body mass index (BMI) of 30 to 40 kg/m 2 willing to follow a diet and exercise program. All Obalon balloons must be removed in 6 months. Patients with prior weight loss surgeries are not eligible. Köp aktier i Obalon Therapeutics Inc - enkelt och billigt hos Avanza Bank. Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage. 2021-01-20 The Obalon Balloon System helps facilitate weight loss by taking up space in your stomach so you eat less.
Nalle puh torsdag

Charting, Tear Sheets, Press, Price Performance & more. Analyze up to 10 years of full 10K Annual Reports and Quarterly 10Q SEC filings for Obalon Therapeutics Inc (OBLN) using our online tools.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now Obalon Therapeutics Amended 13D Filing From Domain Partners VII Shows 9.8% Stake In Co. Benzinga Newsdesk Mon, 15 Mar 2021 10:53:38 -0400 44 Stocks Moving In Wednesday's Mid-Day Session Lisa Levin 2021-03-13 · Obalon Therapeutics, Inc. (NASDAQ:OBLN) is a San Diego-based company focused on developing and commercializing novel technologies for weight loss.
Hamnaren

2020-11-27

On July 24, 2018, the Court appointed Inter-Local as Lead Plaintiff. Obalon Therapeutics, Inc. is a commercial-stage medical device company focused on developing and commercializing medical devices to treat obese and overweight people by facilitating weight loss. 2020-12-02 The Obalon Balloon System is intended for adults with a body mass index (BMI) of 30 to 40 kg/m 2 willing to follow a diet and exercise program. All Obalon balloons must be removed in 6 months. Patients with prior weight loss surgeries are not eligible. Köp aktier i Obalon Therapeutics Inc - enkelt och billigt hos Avanza Bank. Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage.